baccaratbarsolaire| U.S. stocks change | Amgen surged nearly 16%, mid-term trial of new weight-loss drugs received positive data Tourism 2024-05-04 美国制药公司安进(AMGNbaccaratbarsolaire.US)盘初大涨近16%至322.6美元baccaratbarsolaire,创2009年以来最大单日涨幅。消息面上,安进减肥新药中期试验获积极数据,如果该药物获得批准,它将与诺和诺德的Wegovy和礼来的Zepbound竞争。此前有媒体称,安进正在尝试一种全新的减肥药,作用机理与诺和诺德和礼来的产品存在差异,可以令患者即使停药,体重也不会反弹。 前一篇nftgamestoearnmoney| Panda Dairy: Currently, the retail business has been deployed in the cheese casual snacks sector, which can achieve rapid growth 后一篇spinbettercasinonodepositbonus| Sycamore International (00613.HK) sells a total of 200 million shares of Itari